November 20, 2020 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det tredje kvartalet 2020
November 20, 2020 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2020
November 19, 2020 Regulatory Promore Pharma meddelar positiva resultat från fas IIb-studie av ropocamptide vid behandling av venösa bensår
November 19, 2020 Regulatory Promore Pharma announces positive results from Phase IIb study of ropocamptide in the treatment of venous leg ulcers
October 27, 2020 Non Regulatory Nomination Committee Appointed for the Annual General Meeting 2021 in Promore Pharma
August 19, 2020 Non Regulatory Inbjudan till presentation av Promore Pharmas delårsrapport för det andra kvartalet 2020
August 19, 2020 Non Regulatory Invitation to Presentation of Promore Pharma’s Interim Report for the Second Quarter 2020
May 26, 2020 Regulatory Report from the Annual General Meeting of Promore Pharma AB held on 26 May 2020
May 25, 2020 Non Regulatory Invitation to Conference Call regarding Promore Pharma’s Interim Report for the First Quarter 2020
May 25, 2020 Non Regulatory Inbjudan till telefonkonferens med anledning av Promore Pharmas rapport för det första kvartalet 2020
March 24, 2020 Regulatory Promore Pharma nådde målsättningen i antalet behandlade patienter i den kliniska fas IIb-studien HEAL LL-37
March 24, 2020 Regulatory Promore Pharma reached the targeted number of patients completing treatment in the HEAL LL-37 Phase IIb clinical trial
February 13, 2020 Non Regulatory Invitation to Presentation of Promore Pharma’s Year-end report for 2019
February 13, 2020 Non Regulatory Inbjudan till presentation av Promore Pharmas bokslutskommuniké för 2019